Published date: 17 March 2022

Withdrawn opportunity - This means that the contract has been withdrawn early. This could be due to a change of circumstances.


Closing: 17 March 2022, 12pm

Contract summary

Industry

  • Research and development consultancy services - 73200000

  • Medical analysis services - 85148000

Location of contract

SW1H 0EU

Value of contract

£280,000

Procurement reference

CF-0607000D0O000000rwimUAA1

Published date

17 March 2022

Closing date

17 March 2022

Closing time

12pm

Contract start date

5 May 2022

Contract end date

31 December 2023

Contract type

Service contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

Yes

Description

The contract is for the provision of a clinical and cost-effectiveness model for Human Papillomavirus (HPV) Screening in vaccinated populations. This model will project and compare the health benefits, harms, and costs associated with a range of strategies for HPV screening in vaccinated populations.

Contract Project reference: C60479

Contract Value: £280,000 excluding VAT; £336,000 including VAT

Contract Term: From 05/05/2022 to 31/12/2023, with the option to extend for 6 months at the sole discretion of the contracting authority and for the purpose of completing the contract outcomes.

The opportunity will be available on the DHSC Atamis eTendering System. Select this link to access and register your organisation to the Atamis system https://health-family.force.com/s/Welcome, if you have not already done so.
To find this opportunity in the eTendering system, select "Find Opportunities" and then search by project number or title. Once you have found the Opportunity, press the 'Register Interest' button to register your interest. This will make the project to appear on 'My proposals and quotes'. From there you can review documents, send clarification messages, submit the response, or decline to respond, if you decide not to participate in the opportunity. See attached document with further help on how to submit a bid.
For full details on the instruction to tender and terms of participations please refer to the Invitation to Tender document.

More information

Previous notice about this procurement

DHSC_OHID_Human Papillomavirus (HPV) Screening In Vaccinated Populations

  • Opportunity
  • Published 14 February 2022

Links

About the buyer

Contact name

Ms Julia Huerta Estruga

Address

39 Victoria Street
London
SW1H 0EU
GB

Telephone

01132045540

Email

julia.estruga@dhsc.gov.uk